Prediction of Muscle Responsiveness to FES Therapy
Key facts
- Who runs it
- University Health Network, Toronto
- Where
- Canada1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 10 people enrolled
- Started
- 20 Jul 2022
- Ended
- 31 Dec 2024
- Type of study
- Interventional
- Treatments tested
- Functional electrical stimulation therapy.
- Record updated
- 15 January 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Cervical spinal cord injury
- Paralysis or paresis in at least one upper extremity
- At least 6 months post SCI
- Able to understand and follow instructions
- Able to tolerate being in a seated position for a least one hour required to deliver upper limb therapy
- Willing to attend treatment sessions and all assessment sessions
- Able to understand and provide informed consent
- Male and female participants ≥ 18 years of age at the time of enrollment
Who cannot take part
- Previous history of any other neuromuscular disorder or conditions that may affect motor response
- Upper extremity injury or condition prior to SCI that limits the function of the hand or arm
- Currently enrolled in another upper limb study and/ or has received MyndMove Therapy within the past 3 months
- Botulinum toxin injection into affected upper extremity and the muscle targeted by MyndMove® therapy within 3 months prior to the study start. No botulinum toxin injections in the upper extremity during the study treatment
- Regional disorder of the upper extremities such as fracture, dislocation, or joint contractures to less than 50% of the expected range of motion
- In the judgment of the medical provider, the participant has medical complications that may interfere with the execution of the study
- Females who are pregnant or planning to become pregnant in the duration of the trial
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Reduced arm and hand function has a significant impact on independence and quality of life after spinal cord injury. Functional electrical stimulation therapy (FES-T) is a treatment that can produce improvements in reaching and grasping function after neurological injuries. However, not all paralyzed muscles respond equally well to the therapy. Currently, therapists cannot predict which muscles will respond, limiting their ability to create a personalized therapy plan that can maximize outcomes while making the best use of the limited treatment time available. The objective of this study is to develop a diagnostic method that will allow therapists to quickly and easily screen muscles in the clinic, in order to predict how they will respond to FES-T.
Read full original descriptionShow less
Participants with cervical spinal cord injury will receive FES-T through the Rocket Family Upper Extremity Clinic at the Toronto Rehabilitation Institute - University Health Network. Muscles receiving training will undergo a electrophysiological examination before the start of therapy, and will then be tracked for strength recovery over the course of 30 sessions. Lastly, signal processing and machine learning techniques will be applied to the electrophysiological data to predict the recovery profile of each muscle.
The significance of this work will be to provide personalized therapy planning in FES-T, leading to more effective use of healthcare resource as well as improved outcomes.
The group in the trial
- Functional electrical stimulation therapyTreatment being tested
Participants will receive 30 sessions of upper limb functional electrical stimulation therapy. Sessions will be 1 hour in length and take place 3-5 times per week.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Point-of-care Prediction of Muscle Responsiveness to Functional Electrical Stimulation Therapy During Neurorehabilitation (sub-study)
- Record updated
- 15 January 2025